Category: CannabisNewsWire Release

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Leveraging DehydraTECH(TM) to Deliver More Effective Oral Medicine

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator of drug delivery platforms, is increasing the effectiveness of orally administered drugs. With oral absorption being the most convenient and widely used route for taking medications, decades of research have advanced the understanding of critical factors controlling oral bioavailability. Scientists are now better understanding the physiological function and formulation functionality that has been used in designing improved and more desirable oral medicine delivery through extensive research. Lexaria is accomplishing this through its patented DehydraTECH(TM) technology. “DehydraTECH improves the way that active pharmaceutical ingredients (‘APIs’) make their way into the bloodstream. This is achieved by promoting healthier ingestion methods and an increase in the effectiveness of fat-soluble active molecules,” explains a recent article. “Lexaria’s DehydraTECH can be summarized by these major benefits: speeds up delivery; increases bioavailability; increases brain absorption; improves drug potency; reduces drug administration costs; and masks unwanted taste. One of Lexaria’s recent human clinical trials (HYPER-H21-2) using DehydraTECH-processed cannabidiol (‘CBD’) evidenced reduced arterial stiffness. The discovery potentially broadens Lexaria’s application’s ability to treat cardiovascular and other diseases beyond hypertension.”

To view the full article, visit https://cnw.fm/UqEil

About Lexaria Bioscience Corp.

Lexaria’s patented drug delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce time of onset from one to two hours to minutes, and mask unwanted tastes. The technology is also being evaluated for orally administered anti-viral drugs, non-steroidal anti-inflammatory drugs (“NSAIDs”), PDE5 inhibitors and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 23 patents granted and over 50 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Marijuana Company of America Inc.’s (MCOA) Strong Financial Performance Reflects Successful Diversification Capabilities, Organic Growth

Marijuana Company of America (OTC: MCOA) is uniquely positioned to benefit from the cannabis market’s growth and associated opportunities as more states and countries worldwide push for the legalization of cannabis. MCOA offers diverse operations that include its cDistro distribution company, as well as hempsmart(TM) and VBF brands, a premium CBD company and a cannabis nursery cultivation facility in Salinas, California, respectively. In addition, the company is building its portfolio of investments and joint ventures, representing the highest standards of professionalism and integrity in the legal cannabis and industrial hemp markets. “MCOA recently reported a significant milestone, reaching the highest quarterly revenue numbers since its inception, according to the company’s financial results report for the third quarter ending Sept. 30, 2021,” reads a recent article that also quotes MCOA CEO Jesus Quintero. “Our Q3 financial performance was strong and reflects our ability, despite being in a challenging environment, to execute on the strategy by diversifying within the cannabis industry through strategic acquisitions along with organic growth,” Quintero said. He further underlined that the company expects to drive continued growth across the entire business in the coming months.

To view the full article, visit https://cnw.fm/GFNLW

About Marijuana Company of America Inc.

Marijuana Company of America operates and invests in the cannabis sector directly. The company’s operations include C-Distro, one of the fastest growing distribution companies in the THC, Hemp and CBD cannabis industries, and hempsmart(TM), a premium CBD company. The company’s core mission is to leverage its experience and access to capital to identify and invest in acquisitions with unique growth potential. For more information, visit www.MarijuanaCompanyofAmerica.com.

NOTE TO INVESTORS: The latest news and updates relating to MCOA are available in the company’s newsroom at http://cnw.fm/MCOA

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — New Study Finds Cannabis Breathalyzers Provide Inaccurate Results

New research has found that cannabis breathalyzers are inconsistent in measuring THC impairment. THC (tetrahydrocannabinol) is the primary psychoactive compound in marijuana that induces a high. This compound usually binds with receptors in the brain that control mood and pain, among other feelings.

The study was carried out in Australia by University of Sydney researchers.

For their research, the investigators conducted an analysis of 28 studies on the concentration of THC in saliva and blood and driving performance. The studies included in the analysis focused on how THC divided attention and impacted an individual’s reaction time. These two skills are necessary for safe driving.

The idea of cannabis breathalyzers is based on alcohol breathalyzers, which are used to assess an individual’s blood alcohol levels. These devices are mostly used by law enforcement officers and administered on the road. Alcohol breathalyzers have been used efficiently for a while now to provide relatively accurate evaluations on intoxication levels and how they impact a person’s driving skills.

However, marijuana breathalyzers don’t seem to be doing the same in providing accurate levels of THC impairment. The researchers’ analysis showed that the link between driving performance and THC impairment was inconsistent. Despite this inconsistency, the researchers also discovered strong connections between impairment and levels of THC in inexperienced marijuana users. However, once marijuana users used the herb several times in a week, these connections disappeared.

In their report, the lead author of the study, Dr. Danielle McCartney, stated that higher concentrations of THC in the blood were weakly linked to increased impairment in occasional marijuana users while no notable relationship was found in regular users of marijuana. McCartney noted that this finding suggests that oral and blood fluid THC concentrations are not the best indicators of marijuana-THC-induced impairment.

Prior studies have also found that THC intoxication presents differently in individuals, as a person who is experienced with marijuana may have the same THC levels in their blood as a person who is  inexperienced with it. This means that while the compound can impair an individual’s driving skills, the two individuals will likely have different responses to the drug and how impaired they are by it.

Cannabis breathalyzers were considered to be a solution for solving driving while under the influence of THC, which is an issue that many associate with cannabis legalization. However, this study has highlighted that the devices need to measure a different biomarker in order to provide an accurate assessment of intoxication, as at the moment, they can only prove that an individual has consumed THC.

The controversy over how to ascertain that someone is driving while impaired by marijuana is in a way similar to the inconsistencies that cannabis beverage makers such as BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) have been facing regarding how many infused drinks a customer can buy at a go while adhering to the total THC concentration limit set by Health Canada as the marijuana laws were formulated.

NOTE TO INVESTORS: The latest news and updates relating to BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) are available in the company’s newsroom at http://cnw.fm/BVNNF

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Report Finds State-Legal Cannabis Markets Have Generated $10B in Taxes

Cannabis is without a doubt one of the fastest-growing industries in America. Despite being relatively young, America’s state-legal cannabis industry has been quite lucrative, generating billions of dollars in revenue and creating hundreds of thousands of new job opportunities. According to a newly released report on the industry, marijuana has been extremely kind to state coffers; since 2014, cannabis sales have provided states with legal marijuana markets more than $10 billion in tax revenue.

The Marijuana Policy Project report states that since Colorado and Washington state sanctioned recreational cannabis sales in 2012, a wave of cannabis reform has swept across the country. By December 2021, 18 states in total had legalized adult-use cannabis and earned a whopping $10.4 billion in tax from cannabis sales. Since most marijuana reform laws had a strong emphasis on social equity, a significant portion of the billions of tax dollars has been used to fund various social equity programs, the report says.

According to Karen O’Keefe, the director of state policies at Marijuana Policy Project, the states that chose to legalize recreational cannabis have reaped “significant economic benefits” from the controversial but in-demand plant. The tax revenue from cannabis sales has been used to fund several public services, including ones meant to reinvest in communities that were disproportionately affected by the war on drugs. Compared to the decades-long drug war, which cost taxpayers billions of dollars per year, cannabis reform is actually pouring money back into the community, especially for the most disadvantaged ones.

The drug war was ostensibly started to address drug abuse rates and defund the criminal enterprises behind the drug trade, but after decades of intense policing and harsh sentencing, Black and Latino communities around the country were left decimated. Most states with legal cannabis markets have earmarked funds from marijuana taxes to help address this damage. Alaska, for instance, directs half of its recreational cannabis sales taxes to the Recidivism Reduction Fund as well as reentry programs for current and former convicts.

In California, more than $100 million in cannabis sales taxes have been dispensed to nonprofit and community groups that aid individuals who were negatively affected by the drug war. The state, which collected around $817 million in cannabis sales revenue in the fiscal year 2020­–21, announced last year that it would provide grants worth $29 million to 58 organizations to help alleviate the effects of the failed drug war. Colorado has invested almost $500 million in the public school system while Illinois is spending a portion of its cannabis tax revenue on much-needed mental health services.

These huge numbers with respect to the taxes and fees that states have collected from the marijuana industry are a reflection of how quickly sector players such as American Cannabis Partners have scaled their operations so as to meet the growing demand for legally sourced cannabis products.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Alternative Products Expo Announces March Debut with Thousands of Products Under One Roof

The first Alternative Products Expo of 2022 will be held March 11–13, 2022, at the Broward County Convention Center in Ft. Lauderdale, Florida. Formerly known as the USA CBD Expo, the Alternative Products Expo features more than 50 expert speakers and insightful presentations, as well as more than 300 vendors providing a look at thousands of alternative products. Presented by 3Chi, the nation’s largest CBN and Delta-8 distributor, the upcoming expo builds on the foundation established by the USA CBD Expo, which had grown to become North America’s largest CBD-focused event. The new event has added a more comprehensive overview into the alternative product ecosystem and includes a focus on products such as functional beverages, cannabis derivatives, vape products, mood enhancers, herbal products, energy boost supplements and dietary supplements. The expo is a must-attend event for both industry newcomers and professionals with educational seminars, keynote addresses, workshops and networking opportunities.

To attend the expo, visit https://cnw.fm/NLSzW

To view the full press release, visit https://cnw.fm/gDpzl

About Alternative Products Expo

The USA CBD Expo is rebranding as the Alternative Products Expo to better reflect the variety of exhibitors on the trade show’s floor. The Alternative Products Expo, or AltPro Expo, was created with the idea of bringing together an assortment of industries and the disruptive products and services all under one roof. For more information about the company, visit www.AltProExpo.com 

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – BevCanna Enterprises Inc.’s (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Strong Financial Results Evidence Continued Execution, Brands’ Impact on Market

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health and wellness beverage and natural products company, recently released its unaudited financial results for the fiscal quarter ended Sept. 30, 2021. The company saw revenues increase by more than 1,000% to $1.1 million with a gross profit of $356,168, a significant turnaround from the loss of $40,280 recorded in Q3 2020. A recent article quotes BevCanna Chief Financial Officer John Campbell as saying, “As we closed out the third quarter, we delivered impressive revenue growth of more than 1,000%, achieving $1.1 million in sales, compared to $94,000 in the year-ago quarter… Our third-quarter results are further evidence of the company’s continued execution and the impact that our brands are having on the market.” BevCanna has recorded a number of operational highlights over the past few weeks, which have contributed to its top-line revenue growth. A key driver of this growth has been the receipt of initial product listings and purchase orders, which in turn have resulted in shipments to British Columbia and Ontario. “BevCanna Enterprises has also worked towards broadening its product portfolio… [and] has arrived at a definitive agreement to acquire Embark Health Inc.”

To view the full article, visit https://cnw.fm/zfNeM

About BevCanna Enterprises Inc.

BevCanna Enterprises is a diversified health and wellness beverage and natural products company. BevCanna develops and manufactures a range of alkaline, plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients. With decades of experience creating, manufacturing and distributing iconic brands that resonate with consumers on a global scale, the team demonstrates an expertise unmatched in the nutraceutical and cannabis-infused beverage categories. Based in British Columbia, Canada, BevCanna owns a pristine alkaline spring water aquifer and a world–class 40,000–square–foot, HACCP-certified manufacturing facility, with a bottling capacity of up to 210M bottles annually. BevCanna’s extensive distribution network includes more than 3,000 points of retail distribution through its market-leading TRACE brand, its Pure Therapy natural health and wellness e-commerce platform, its fully licensed Canadian cannabis manufacturing and distribution network, and a partnership with top U.S. cannabis beverage company Keef Brands. For more information about the company, visit www.BevCanna.com.

NOTE TO INVESTORS: The latest news and updates relating to BVNNF are available in the company’s newsroom at http://cnw.fm/BVNNF

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Cannabis Strategic Ventures Inc. (NUGS) Strengthening Position Amid Growing Support for Cannabis Legalization

Cannabis Strategic Ventures (OTCQB: NUGS), an emerging leader in the U.S. cannabis marketplace, is one of the companies set to benefit as a growing number of Americans across various age groups and political affiliations support the legalization of cannabis. While cannabis remains an illegal substance federally, a growing number of states have legalized the substance. Cannabis Strategic Ventures, which is establishing a strong foothold in the industry, is guided by the vision to acquire and scale assets in the legal cannabis market while achieving efficiencies through economies of scale and vertical integration. A recent article reads, “As part of that vision, Cannabis Strategic Ventures owns NUGS Farm North, a six-acre cannabis farm in Northern California. In addition, the company is committed to taking other steps to strengthen its position in the growing market, including working toward taking operational control of each license. The company also recently celebrated the opening of its cannabis dispensary and is looking to deploy another license to establish an indoor cultivation facility with capacity to produce two to three pounds of premium cannabis flower per light, per harvest.”

To view the full article, visit https://cnw.fm/bqHWf

About Cannabis Strategic Ventures Inc.

Cannabis Strategic Ventures is one of the largest publicly traded marijuana cultivators in the United States. The company is Los Angeles-based and incubates, develops and partners with category leaders within the cannabis and ancillary sectors. The firm’s NUGS brand experience provides operational and financial strategic partnerships and a range of essential services to emerging and existing Cannabis consumer brands. For more information, visit www.CannabisStrategic.com.

NOTE TO INVESTORS: The latest news and updates relating to NUGS are available in the company’s newsroom at http://cnw.fm/NUGS

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Illinois Breaks Yet Another Cannabis Sales Record in December

All things considered, 2021 was a pretty good year for cannabis. Unlike most sectors, the state-legal cannabis industry didn’t take much of a beating from the coronavirus pandemic, and when 2021 came to a close, cannabis businesses across the country were doing relatively well. So while businesses in other industries were struggling to recover from the crippling effects of the pandemic, marijuana sellers were making bank. For Illinois, 2021 was probably the best year the state’s cannabis industry had ever seen.

Cannabis sellers in Illinois sold cannabis worth a whopping $137.9 million in December 2021, breaking yet another monthly sales record. December was the market’s best-selling month, with the state’s cannabis industry breaking the monthly record of $127.8 million in sales that was set in July. Furthermore, says the Illinois Department of Financial and Professional Regulation, marijuana sales in Illinois doubled over the course of the year from $669 million in 2020 to a whopping $1.4 billion in 2021.

Illinois residents made up the majority of the cannabis market, buying $943 million worth of cannabis products while out-of-state visitors purchased marijuana products worth more than $436 million. The year was also quite lucrative for the taxman. Since taxes on legal sales can be up to 40% of the price, the state was able to collect $387 million worth of taxes from cannabis sales. More than one-third of the tax funds were earmarked for the state general revenue fund, with 10% going to unpaid bills, 8% going to law enforcement and 2% going to public safety campaigns.

The Restore, Reinvent and Renew program diverted almost a quarter of every marijuana dollar to social equity programs targeting communities that had been disproportionately affected by the war on drugs. The funds were used to provide these communities with crucial services such as youth development, legal aid, financial support and community reentry. In December 2021, state officials announced that the state would provide $45 million in grants to communities that were harmed most by the decades-long drug war.

To identify such communities and determine their social equity eligibility, officials examined community-level data on child poverty, unemployment, gun injury and state prison commitments. Speaking at a press conference in December 2021, Illinois Governor J.B. Pritzker said that it was time to address the damage caused by the failed war on drugs. He said that what set Illinois apart from other states was its commitment to reinvesting in these impacted communities now that cannabis is legal. Earlier last year, the Restore, Reinvent and Renew program distributed $31.5 million in social equity grants to 80 organizations.

This boom in marijuana sales may suggest that cannabis sector players in that market such as Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) may have cracked the code of what the consumers in that market need, hence the record sales.

NOTE TO INVESTORS: The latest news and updates relating to Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) are available in the company’s newsroom at https://cnw.fm/RWBYF

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Two DEA-Approved Firms Harvest Cannabis Crop, Ending MU Cultivation Monopoly

After more than five decades of being in place, the federal monopoly on marijuana manufacturing ended earlier last week. Before its cessation, only the University of Mississippi was allowed by the Drug Enforcement Administration (“DEA”) to grow cannabis for study purposes.

The DEA had in the recent past announced that it would take action to end the monopoly and permit additional manufacturers. In May of last year, a number of companies received conditional approvals for their applications. Two of them — the Biopharmaceutical Research Company (“BRC”) and Groff North America Hemplex — revealed that they had recently received official registration from the DEA and had begun to grow and harvest the crop.

BRC concluded its first harvest in November 2021 and is now focused on its second harvest of marijuana plants under its DEA license. Gross North America Hemplex also concluded its first harvest towards the end of December 2021. The company is making arrangements with various Schedule I substance researchers to scale up the development of its produce.

Researchers state that this development represents a step forward, with the DEA beginning to oversee the production of research-grade marijuana on a new and much larger scale.

In an interview, Biopharmaceutical Research CEO George Hodgin stated that these steps had been made because of the work advocates of the marijuana community had done over the last few decades.

Advocates, health officials and legislators alike have been calling for expanded marijuana research, with most arguing that the current supply of government-grown cannabis for research was inadequate and that its products were chemically different from what consumers were purchasing in state-legal markets.

In a recent interview, Nora Volkow, director of NIDA, stated that researchers being allowed to access marijuana from retailers would be valuable as it would help to better understand the benefits and risks of what individuals were consuming in different states. In November 2021, President Joseph Biden signed an infrastructure legislation, which includes provisions that will provide researchers with this access.

Over in Congress, members are calling for the DEA to permit terminally ill patients to use psilocybin as an investigational therapy without fear of being federally prosecuted. Rep. Earl Blumenauer has been circulating a letter that highlights the existence of federal and state right-to-try laws that should allow eligible patients to access the psychedelic based on the promising potential it’s shown in various ongoing clinical trials.

This comes after a doctor in Washington State filed a lawsuit against the DEA for its refusal to allow him access to treat terminal patients using magic mushrooms.

The end of the cannabis production monopoly is likely to help the field of marijuana research, and the entire industry, including sector actors such as Simply Sonoma Inc., will benefit from that increased research.

NOTE TO INVESTORS: The latest news and updates relating to Simply Sonoma Inc. are available in the company’s newsroom at https://cnw.fm/Sonoma

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Sugarmade Inc. (SGMD) Verticalizing Operations, Expanding End-Market Access in California Cannabis Delivery Marketplace

Sugarmade (OTC: SGMD), an innovator in the dynamic California cannabis sector, is leveraging the combination of NUG Avenue’s high performance and new delivery technology as it moves forward with expansion plans. NUG, which opened its doors at its initial location in March 2021, had gathered more than 10,000 unique members by the end of June 2021. This growth has only increased. NUG Avenue has also added new technology designed specifically to strengthen the company’s competitive advantage in its core delivery zone. Additionally, SGMD has submitted all documentation for the opening of a second NUG Avenue location. The company’s management is also looking for additional properties for further expansion, including outside of the LA marketplace. “Expanding NUG Avenue isn’t the only growth in Sugarmade’s future. The company is taking active steps toward the first planting at its subsidiary Lemon Grow, a large 640-acre outdoor cultivation site,” reads a recent article. “Sugarmade has set its eyes on expanding its end-market access as a central player in the growing California cannabis delivery marketplace while also developing its in-house cannabis production capacity to verticalize operations in the space.”

To view the full article, visit https://cnw.fm/RZfQB

About Sugarmade Inc.

Sugarmade is a product and branding marketing company investing in operations and technologies with disruptive potential. The company’s brand portfolio includes CarryOutsupplies.com, SugarRush, NUG Avenue, Lemon Glow, and Budcars. For more information, please visit www.Sugarmade.com.

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://cnw.fm/SGMD

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.